tert-Butyl 4-[(6-fluoroquinolin-2-yl)methyl]piperazine-1-carboxylate

Catalog No. :
ACTMYW691
CAS No. :
1221411-13-7
Molecular Formula :
C19H24FN3O2
Molecular Weight :
345.42

IUPAC Name:tert-butyl 4-((6-fluoroquinolin-2-yl)methyl)piperazine-1-carboxylate

tert-Butyl 4-[(6-fluoroquinolin-2-yl)methyl]piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-[(6-fluoroquinolin-2-yl)methyl]piperazine-1-carboxylate
IUPAC Nametert-butyl 4-((6-fluoroquinolin-2-yl)methyl)piperazine-1-carboxylate
MDL No.MFCD16295226
Molecular FormulaC19H24FN3O2
Molecular Weight345.42
SMILESO=C(N1CCN(CC2=NC3=CC=C(F)C=C3C=C2)CC1)OC(C)(C)C
InChI KeyAIKMYPBUNXDSJT-UHFFFAOYSA-N
Synonym1-Piperazinecarboxylic acid, 4-[(6-fluoro-2-quinolinyl)methyl]-, 1,1-dimethylethyl ester;tert-Butyl 4-[(6-fluoroquinolin-2-yl)methyl]piperazine-1-carboxylate
CAS No.1221411-13-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTMYW691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACKIYM678 route compound structure diagram
    ACKIYM678260430-93-1 In Stock
  4. Then
  5. ACTMYW691 route product structure diagram
    ACTMYW6911221411-13-7
Inquiry

2. ACTMYW691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMYW691 route product structure diagram
    ACTMYW6911221411-13-7
Inquiry

Comments (0)